Aarti Drugs Limited Strong Sequential Growth Reported in Q4 and FY26 Financials
Aarti Drugs Limited has reported a robust sequential performance for Q4 FY26, with total revenue rising by 20% and EBITDA surging by 72%…
Akums Drugs and Pharmaceuticals Ltd Submission of Annual Secretarial Compliance Report for FY 2025-26
Akums Drugs and Pharmaceuticals Ltd has formally submitted its Annual Secretarial Compliance Report for the financial year ended March 31,…
Latent View Analytics Board Approves Key Leadership Reappointments
Latent View Analytics has announced the reappointment of four key directors to the company’s board. The reappointments, approved by the…
Aarti Drugs Limited Reports Strong Q4 and FY26 Performance Amid Strategic Scaling
Aarti Drugs Limited has announced its financial results for the quarter and fiscal year ending March 31, 2026. The company achieved a revenue…
Akums Drugs and Pharmaceuticals Ltd Update on Haridwar Manufacturing Operations
Akums Drugs and Pharmaceuticals Limited has announced the resumption of manufacturing operations at its Haridwar facilities following a period…
Afcons Infrastructure Cancellation of Croatian Road Project Tenders
Afcons Infrastructure has been notified by Croatian Motorways Ltd that two road construction tenders, Package J324/23 and Package J325/23,…
KIMS Hospitals Financial Results for Q4 and FY 2026
Krishna Institute of Medical Sciences (KIMS) Hospitals reported a strong financial year for FY 2026, with a 28.2% YoY growth in total revenue…
KIMS Hospitals Financial Results and Strategic Growth Overview for FY26
Krishna Institute of Medical Sciences (KIMS) Hospitals has released its performance summary for the financial year ended March 31, 2026. The…
Shyam Metalics and Energy Limited Strong Financial Performance and Strategic Expansion in FY26
Shyam Metalics and Energy Limited has reported a strong performance for the full year FY26, with revenue growing 22% and profitability…
OneSource Specialty Pharma Limited Karnataka Government Approves Unit II Expansion
OneSource Specialty Pharma Limited has secured in-principle approval from the Government of Karnataka for its Unit II expansion project. This…